– Alamar Biosciences lanza el kit de desarrollo de ensayos personalizados NULISAqpcr™ para avanzar en el desarrollo de nuevos ensayos de biomarcadores para la investigación clínica FREMONT, Calif., 24 de febrero de 2025 /PRNewswire/ — Alamar Biosciences, una empresa que impulsa la…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.